Hanover Bancorp (HNVR) CFO receives 3,185-share restricted stock grant

Rhea-AI Filing Summary

Hanover Bancorp, Inc. reported that its Senior Executive Vice President and Chief Financial Officer, Lance P. Burke, received an equity grant in the form of restricted common stock. He was awarded 3,185 shares on February 5, 2026, at a price of $0.0000 per share, increasing his directly held beneficial ownership to 29,142 common shares.

The grant is structured to vest over three years, with one-third of the shares vesting on each of March 1, 2027, March 1, 2028, and March 1, 2029, and is subject to forfeiture conditions typically tied to continued service or performance.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Burke Lance P

Role SEVP & Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,185	$0.00	--

Holdings After Transaction: Common Stock — 29,142 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Burke Lance P

(Last) (First) (Middle)

C/O HANOVER BANCORP, INC.

80 EAST JERICHO TURNPIKE

(Street)

MINEOLA NY 11501

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hanover Bancorp, Inc. /MD [ HNVR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SEVP & Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/05/2026		A		3,185(1)	A	$0.0000	29,142	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock subject to forfeiture, vesting over a three year period, with 1/3 vesting on each of March 1, 2027, March 1, 2028, and March 1, 2029.

	/s/ Lance P. Burke	02/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Hanover Bancorp (HNVR) disclose for Lance P. Burke?

Hanover Bancorp disclosed that SEVP & CFO Lance P. Burke received a grant of 3,185 shares of restricted common stock. The award was reported as acquired at $0.0000 per share, reflecting a compensatory equity grant rather than an open-market purchase.

How many Hanover Bancorp (HNVR) shares does Lance P. Burke own after this grant?

Following the restricted stock grant, Lance P. Burke beneficially owns 29,142 shares of Hanover Bancorp common stock directly. This figure includes the newly granted 3,185 restricted shares, which are subject to vesting and potential forfeiture over a three-year period.

What are the vesting terms of Lance P. Burke’s restricted stock in Hanover Bancorp (HNVR)?

The 3,185 restricted shares granted to Lance P. Burke vest over three years. One-third vests on March 1, 2027, another third on March 1, 2028, and the final third on March 1, 2029, with the award subject to forfeiture conditions.

Was the Hanover Bancorp (HNVR) insider stock grant an open-market transaction?

No, the transaction was reported as an acquisition of restricted stock at $0.0000 per share. This indicates it was a compensatory equity grant to the executive, not an open-market purchase or sale on a stock exchange.

Which Hanover Bancorp (HNVR) executive received the reported restricted stock award?

The award was granted to Lance P. Burke, who serves as Senior Executive Vice President and Chief Financial Officer of Hanover Bancorp, Inc. He is listed as the sole reporting person on the Form 4 and holds the shares directly.

Over what period will the Hanover Bancorp (HNVR) restricted shares for Lance P. Burke fully vest?

The restricted stock grant will fully vest over approximately three years. Equal portions are scheduled to vest on March 1, 2027, March 1, 2028, and March 1, 2029, assuming the vesting conditions are satisfied throughout the period.